Forecast of Global Growth in Antipsychotic Drugs Market By 2021 June 2017

Global Antipsychotic Drugs Market 2017-2021
Global Antipsychotic Drugs Market report covers the present scenario and the growth prospects of the
industry for 2017-2021. To calculate the market size, the report considers sales from both branded and
generic drugs. The analysts forecast global Antipsychotic Drugs market to grow at a CAGR of 1.84%
during the period 2017-2021.
Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used
for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar
disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of
schizophrenic patients.
Inquire Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=1041437
Key vendors
The key players in the Antipsychotic Drugs Market are AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson &
Johnson.
Other Prominent Vendors
Other Prominent Vendors in the market are Actavis Generics (a subsidiary of Teva Pharmaceutical
Industries), Alkermes, Bristol-Myers Squibb.
Purchase Report Directly @ http://www.reportsnreports.com/purchase.aspx?name=1041437
Market driver
Increasing expenditure on prescription drugs.
Market challenge
Lack of standard diagnostic methods.
Market trend
Rising public interest toward mental health.
The report, Global Antipsychotic Drugs Market 2017-2021, has been prepared based on an in-depth
market analysis with inputs from industry experts. This report covers the market landscape and its
growth prospects over the coming years. The report also includes a discussion of the key vendors
operating in this market.
Complete Report Available @ http://www.reportsnreports.com/reports/1041437-global-antipsychotic-
drugs-market-2017-2021.html